Stock Analysis
Data Source: SEC EDGAR 13F
Updated Hourly

Oramed Pharmaceuticals Inc (ORMP)

84 + Investors. Track Smart Money conviction in ORMP. See who's accumulating, reducing, or initiating positions.

Current Price
-- USD
Analyst Target
-- (0 analysts)
Upside
0.00%
Net Flow Q/Q
↑ +21
Streak
3Q ▲
Buyers last Q
64%

Smart Money Signals — ORMP

Based on 84 hedge funds · latest filing: 2026 Q2 · updated quarterly

📈

Buying streak — 3 quarters in a row

last 6Q
For 3 consecutive quarters, more hedge funds added ORMP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.
🏔️

At the ownership peak (100% of max)

100% of all-time peak
84 hedge funds hold ORMP right now — the highest count in 3.0 years. When ownership is this concentrated, any bad news can trigger a chain reaction: one big fund sells, others follow. This is a classic 'crowded trade' — high popularity doesn't equal safety.
🚀

Fast accumulation — +75% more funds vs a year ago

fund count last 6Q
+36 new funds entered over the past year (+75% YoY). That's a rapid rush of institutional money. Fast accumulation often signals a major thesis — but it also means the stock could fall quickly if that thesis breaks. The peak was reached in just 3 quarters from the low — a sharp move.
🟢

More buyers than sellers — 64% buying

49 buying28 selling
Last quarter: 49 funds were net buyers (30 opened a brand new position + 19 added to an existing one). Only 28 were sellers (19 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.
📈

More new buyers each quarter (+12 vs last Q)

new funds entering per quarter
Funds opening a new ORMP position: 4 → 14 → 18 → 30. A growing influx of new institutional buyers means the asset is still gathering momentum — the consensus hasn't fully saturated yet.
🔒

49% of holders stayed for 2+ years

■ 49% conviction (2yr+) ■ 23% medium ■ 29% new
41 out of 84 hedge funds have held ORMP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.
💰

Value +59% but shares only +13% — price-driven

Value
+59%
Shares
+12%
Last quarter: the total dollar value of institutional holdings rose +59%, but actual share count only changed +13%. The gap is explained by the stock's price rising — not new buying. Strong value growth with weak share growth means the rally is price momentum, not fresh institutional demand.
🚀

Acceleration phase — new buyers rushing in

4 → 4 → 14 → 18 → 30 new funds/Q
New funds entering each quarter: 4 → 14 → 18 → 30. The pace of institutional discovery is accelerating sharply. This is the 'hot idea' phase — the thesis is being passed from fund to fund. You are not late — the accumulation wave is still building.
🏛️

Veteran-anchored — 68% veterans vs 25% newcomers

■ 68% veterans ■ 7% 1-2yr ■ 25% new
Entry-cohort mix of 85 holders: 58 (68%) are 2+ year veterans, 6 entered 1–2 years ago, and 21 (25%) joined within the past year. A veteran-weighted cap table skews toward institutional memory over fresh momentum.
✅

Strong quality — 26% AUM from major funds

26% from top-100 AUM funds
29 of 84 holders rank in the top 100 by AUM, accounting for 26% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.
4.7
out of 10
Moderate Exit Risk
Exit risk score 4.7/10 — some crowding factors present, but no critical concentration. Watch ownership trend over the next 1–2 quarters for direction.

Methodology note: these Smart Money cards use consecutive 13F disclosure snapshots, not trade-by-trade execution data. "Buying", "selling", "new holders", and "trimmed" refer to quarter-over-quarter changes in reported holders, aggregate shares, or disclosed position values between filings. They are useful for ownership regime analysis and crowding, but they do not imply exact trade timing on the filing date.

Institutional Sentiment Summary — ORMP

In 2026 Q2, 49 hedge funds were net buyers of ORMP (30 opened a new position, 19 added to an existing one), while 28 reduced or exited (19 trimmed, 9 sold completely) — a 64% buyer ratio, indicating clear institutional accumulation. This marks 3 consecutive quarters of net institutional buying — a persistent conviction signal. 26% of total institutional value in ORMP is held by top-100 AUM funds, reflecting strong institutional quality. Net fund flow last quarter: +21 funds (more new holders than closures). Total institutional holders: 84.

Hedge Fund Ownership: ORMP

How many hedge funds hold ORMP — quarterly history vs. share price
Quarterly hedge fund ownership of ORMP vs. share price

Market Analysis: ORMP

Analyst Price Targets

Avg. Price Target
--

Analyst Recommendations

Stock Performance

Real-time

Company Profile: ORMP

-- --

Institutional ownership data sourced from SEC EDGAR Form 13F-HR filings.

Loading signal freshness…
Smart Money Signal ?
Limited Smart Money Interest

No strong consensus or elite conviction detected among institutional holders.

6 top-rated funds 2 high-conviction
Consensus
3.7
/ 10
breadth
×
Elite
2.4
/ 10
conviction
Hedge Fund Positioning: ORMP
84 + Investors

Track Smart Money conviction in ORMP. See who's accumulating, reducing, or initiating positions.

Metric All 13F Filers (2026 Q2) Prior (2026 Q1) Change
Funds Holding 84 63 33.33%
13F Shares 15M 13M 12.57%
Total Value $71M $45M 59.34%
New Positions 30 18 +12
Increased Positions 19 19 -
Closed Positions 9 10 -1
Reduced Positions 19 14 +5
Total Calls 1 0 100%
Total Puts 0 0 -
PUT/CALL Ratio 0.0 0.0 Bullish

Statistics: ORMP

View More

Valuation Measures Data as of: --

Market Cap --
Enterprise Value --
Trailing P/E --
Forward P/E --
PEG Ratio (5yr expected) --
Price/Sales (ttm) --
Price/Book (mrq) --
Enterprise Value/Revenue --
Enterprise Value/EBITDA --
Beta (5Y Monthly) --
Short Ratio (Days to Cover) --
Short % of Float --

Financial Highlights

Profitability
Profit Margin --
Return on Assets (ttm) --
Return on Equity (ttm) --
Income Statement & Cash Flow
Revenue (ttm) --
Net Income Avi to Common (ttm) --
Diluted EPS (ttm) --
Total Cash (mrq) --
Total Debt/Equity (mrq) --
Levered Free Cash Flow (ttm) --

Institutional Holders (2026 Q2)

84 + investors

Explore institutional interest and hedge fund ownership dynamics. Analyze portfolio weights, new positions, and conviction trends in ORMP. Verified SEC 13F-HR filings.

QUARTER:
Top 25 ORMP holders by conviction (% of portfolio weight) — 2026 Q2 · Source: SEC Form 13F
# Investor % of Portfolio Shares Mkt Value
1 Gem Investment Advisors, LLC 5.89% 1,998,802 $9.6M
2 BML Capital Management, LLC 2.37% 866,269 $4.2M
3 Murchinson Ltd. 0.86% 1,290,294 $6.2M
4 Aquamarine Financial (Cayman) Ltd 0.67% 2,512,175 $12.1M
5 Redwood Family Wealth LLC 0.09% 20,745 $100K
6 Boothbay Fund Management, LLC 0.04% 578,638 $2.8M
7 Sage Capital Management, LLC 0.03% 17,977 $86K
8 Glass Jacobson Investment Advisors llc 0.02% 10,540 $51K
9 Prelude Capital Management, LLC 0.01% 32,713 $157K
10 Mercer Global Advisors Inc /Adv 0.01% 1,910,540 $9.2M
11 Hillsdale Investment Management Inc. 0.01% 89,300 $430K
12 Pioneer Family Office, LLC 0.01% 3,000 $14K
13 Ritholtz Wealth Management 0.01% 84,347 $406K
14 Rathbones Group PLC 0.00% 233,018 $1.1M
15 Bailard, INC. 0.00% 32,478 $156K
16 XTX Topco Ltd 0.00% 49,923 $240K
17 Caitlin John, LLC 0.00% 1,000 $5K
18 Strs Ohio 0.00% 133,800 $644K
19 O'shaughnessy Asset Management, LLC 0.00% 102,962 $495K
20 Algert Global LLC 0.00% 28,958 $139K
21 Y-Intercept (Hong Kong) Ltd 0.00% 12,817 $62K
22 Renaissance Technologies LLC 0.00% 183,800 $884K
23 N.E.W. Advisory Services LLC 0.00% 3,429 $16K
24 Hrt Financial LP 0.00% 97,582 $469K
25 Engineers Gate Manager LP 0.00% 12,698 $61K
Investor Ownership
History 		% of Portfolio Prev % Rank Conviction Avg Buy Price 13F Score™ 3Y / 7Y Sell Timing Shares Mkt Value Change Change % Source Quarter Filed

Frequently Asked Questions — Oramed Pharmaceuticals Inc (ORMP)

What does the Smart Money Trend signal show for ORMP?

Buying streak — 3 quarters in a row: For 3 consecutive quarters, more hedge funds added ORMP than sold it. That's a consistent pattern of professional buying — not a one-time trade. When institutions keep buying quarter after quarter, it usually means they see a multi-year opportunity, not just a short-term momentum flip.

What is the institutional breadth score for ORMP?

More buyers than sellers — 64% buying: Last quarter: 49 funds were net buyers (30 opened a brand new position + 19 added to an existing one). Only 28 were sellers (19 trimmed + 9 sold completely). A clear majority buying is a strong confirmation signal.

What is the fund quality score for ORMP holders?

Strong quality — 26% AUM from major funds: 29 of 84 holders rank in the top 100 by AUM, accounting for 26% of total institutional value held. A meaningful share of the ownership value comes from the most well-resourced institutions.

How long have hedge funds held ORMP?

49% of holders stayed for 2+ years: 41 out of 84 hedge funds have held ORMP for over 2 years without selling. Long-term investors are generally harder to shake out during market stress, creating a stable ownership base that limits the risk of sudden capitulation.

Where does this institutional ownership data come from?

All holdings data is sourced from SEC Form 13F filings, which institutional investment managers with over $100 million in assets are required to submit quarterly. Data is parsed directly from SEC EDGAR.

Disclaimer: The information on this page is for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. Institutional holdings data is sourced from SEC Form 13F filings and reflects positions as of the filing date. Past performance of any fund or portfolio is not indicative of future results. 13Foresight is not a registered investment adviser. Always conduct your own due diligence before making investment decisions.

Full history →